ERHSX Holdings Information

ERHSX is a mutual fund with a total of 46 individual holdings. The top holdings are Eli Lilly and Company stock at 12.85%, AbbVie at 6.66%, AstraZeneca at 5.74%, Johnson & Johnson at 5.21%, and Roche Holding AG at 5.06%.

Total Holdings

Top 10 Percentage

53.36%

Asset Class

Equity

Fund Category

Health

Assets

858.03M

Forward PE Ratio

19.27

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	12.85%	102,873
2	ABBV	AbbVie Inc.	6.66%	250,866
3	LON: AZN	AstraZeneca PLC	5.74%	266,858
4	JNJ	Johnson & Johnson	5.21%	216,808
5	SWX: ROG	Roche Holding AG	5.06%	105,518
6	ABT	Abbott Laboratories	4.15%	285,113
7	BMY	Bristol-Myers Squibb Company	3.53%	563,654
8	UNH	UnitedHealth Group Incorporated	3.50%	91,226
9	ISRG	Intuitive Surgical, Inc.	3.43%	52,181
10	TMO	Thermo Fisher Scientific Inc.	3.22%	47,835
11	VRTX	Vertex Pharmaceuticals Incorporated	2.99%	56,841
12	ZTS	Zoetis Inc.	2.93%	200,609
13	EPA: SAN	Sanofi	2.87%	254,833
14	BSX	Boston Scientific Corporation	2.70%	243,280
15	GILD	Gilead Sciences, Inc.	2.69%	188,375
16	DHR	Danaher Corporation	2.67%	100,506
17	SYK	Stryker Corporation	2.24%	54,948
18	MDT	Medtronic plc	2.07%	185,134
19	ASX: CSL	CSL Limited	1.79%	134,162
20	SWX: LONN	Lonza Group AG	1.72%	21,984
21	ARGX	argenx SE	1.71%	17,543
22	MRK	Merck & Co., Inc.	1.55%	126,571
23	CPH: NOVO.B	Novo Nordisk A/S	1.51%	256,946
24	EW	Edwards Lifesciences Corporation	1.45%	146,286
25	MTD	Mettler-Toledo International Inc.	1.41%	8,731

Showing 25 of 46 holdings

Subscribe to see the full list

Activate Now

As of Dec 31, 2025